T2 Biosystems (NASDAQ:TTOO) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a report released on Friday. The brokerage issued a sell rating on the medical equipment provider’s stock.

T2 Biosystems Stock Down 6.3 %

T2 Biosystems stock opened at $0.06 on Friday. T2 Biosystems has a one year low of $0.06 and a one year high of $6.95. The business’s fifty day moving average is $0.31 and its 200 day moving average is $1.39.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.